Navigation Links
SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus,Drug-Eluting Coronary Stent Systems

SPIRIT FIRST follow-up analysis shows no stent thrombosis or MACE after one year

NATICK, Mass. and BARCELONA, Spain, May 22, 2007 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today welcomed the results of additional data from the SPIRIT FIRST, II and III Clinical Trials, reaffirming prior safety and efficacy data for the market-leading TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System and XIENCE(TM) V (PROMUS(TM)) Everolimus Eluting Coronary Stent System. The PROMUS Stent is a private- labeled XIENCE(TM) V Stent, manufactured by Abbott and distributed by Boston Scientific. Boston Scientific is the only company to offer the choice of two distinct drug-eluting stent platforms.

The data were presented by Gregg W. Stone, M.D., Chairman and Chief Medical Officer of the Cardiovascular Research Foundation, Medical Center, New York City, at the annual Paris Course on Revascularization (EuroPCR) in Barcelona.

The SPIRIT FIRST three-year clinical follow-up results provided further support for the safety and efficacy of the XIENCE V (PROMUS) Stent, with no additional MACE since one-year follow up. In addition, no acute, sub-acute or late stent thrombosis was seen in either the XIENCE V (PROMUS) or BMS control group through three years.

Dr. Stone's presentation also included results of a pooled analysis of previously reported SPIRIT II and III data, where stent thrombosis rates were shown to be very low for both stents (0.45 percent for the XIENCE V (PROMUS) Stent and 0.25 percent for the TAXUS Stent, p=0.59).

"It is reassuring to see that both stents performed exceptionally well in the SPIRIT Clinical Trials on multiple safety measures including stent thrombosis," said Jeff Goodman, President of International for Boston Scientific. "The data for these two drug-eluting stent platforms continue to reinforce Boston Scientific's leadership position in drug-eluting stent tech
'"/>




Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

Post Your Comments:
(Date:11/25/2009)...WATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtradit...,anon-nucleosidereversetranscriptaseinhibitor(NNRT...useintreatment-experiencedadultswhoareexperiencing...andotherantiretroviral(ARV)agents.Thetraditionalap...nasDUET-1andDUET-2.INTELENCEiscurrentlymarketedint...
(Date:11/25/2009)...GRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBiosciences,...romboticaptamerswithactivecontrolagents,announcedt...atthePiperJaffray21stAnnualHealthCareConferenceatt...tationwillbegivenat1:10pm(EST)onTuesday,December1a...mphasisontheleaddevelopmentprogram,theanticoagulan...
(Date:11/25/2009)...ITY,Calif.,Nov.25/PRNewswire-FirstCall/--Abaxis,In...ringpoint-of-carebloodanalysissystems,announcedtod...er,willpresentatthe21stAnnualPiperJaffrayHealthCar...TheconferencewillbeheldattheNewYorkPalaceHotelinNe...s,manufacturesandmarketsportablebloodanalysissyste...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Microfluidics International Corporation to Report Third Quarter 2009 Financial Results on November 2 2009 14622 1Microfluidics International Corporation to Report Third Quarter 2009 Financial Results on November 2 2009 14622 2Microfluidics International Corporation to Report Third Quarter 2009 Financial Results on November 2 2009 14622 3ViVre Medical Launches Lifesaving Medical Device 5768 1ViVre Medical Launches Lifesaving Medical Device 5768 2Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast 5763 1
...7, 2007 - Interleukin,Genetics, Inc. (AMEX:ILI) an...n Diego today reported at the American College of,...n coronary artery,disease (CAD) and both oxidized ... dependent on pro-inflammatory variants of the,int... "The Influence of Oxidized,Phospholipids and Lp(a...
...29, 2007 - Cytogen,Corporation (NASDAQ: CYTO) toda...l data at the 2007 Annual Meeting of the American,...e in Los Angeles,California April 14-18, 2007. Th...that validate novel approaches to drug,discovery a...ry,Abtides(TM) (Antigen-Binding pepTIDES) and oral...
Other Medicine Technology:ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 2Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 3Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 4
(Date:11/26/2009)...K,Nov.27/PRNewswire/--Withcoldandfluseasonuponus,i...trolthespreadofinfectionsandavoidillness. ,, "W...ttoavoidtransmittingillnessifwe,resick,"saidEileen...rsingdirectorforinfectioncontrolandoccupationalhea..., HospitalforSpecialSurgeryhasoneofthelowestinfe...
(Date:11/26/2009)... too big or too heavy can lead to strains or worse...-- There may be nothing wrong with stuffing your t...do the same thing with your suitcase as you pack f...e treated in 2008 in U.S. hospital emergency rooms...lities for luggage-related injuries, such as muscl...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a...rolina, today announced the expansion of its servi...entist, Dr. Doug Macmillan. , ...ntal is pleased to announce that Dr. Doug Macmilla...mpleted an additional advanced training seminar. ...
(Date:11/25/2009)...CITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConventi...icalcliniconDec.9-10,whenKansasCityhoststhelatesti..., "Thisfreecliniceventhasthepotentialtobethebigg...ustoneandbeheldonweekdaysinsteadofoveraweekend,"Sh...ClinicandpresidentoftheNationalAssociationofFreeCl...
(Date:11/25/2009)...ACH,Calif.,Nov.25/PRNewswire/--Thanksgivingmealswi...nthegreaterLongBeachareathankstoFaithInAction/Volu...atHome(IAH),adivisionofSCANHealthPlan.Formorethan1...nteerstodeliverwarmThanksgivingmealstoseniorsinnee...Angelesandsurroundingcities. ,, "Ourwarmholiday...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...Jewelry Collection Donates 100% of Net Profits to ...und, NEW YORK, Sept. 11 L,Oreal Paris proudly co... with The Ovarian Cancer Research,Fund (OCRF) and ...n afflicted with ovarian cancer, helping raise ove...
...PAUL (Sept. 11, 2007) University of Minnesota res... available as a health food supplement, may help c...t eight-week trial, 27 people were given increasin...the trial, 60 percent of the participants reported...
...11 Mediware Information,Systems (Nasdaq: MEDW ) ...ital and Decatur (Ill.) Memorial Hospital have imp...ansfusion Management software system. More than,30...une 30, 2007) more than 60 of these facilities wer...
..., Sept. 11 Transcept,Pharmaceuticals, Inc., a spe... new patient benefits from proven CNS drugs, today...hief Executive Officer is scheduled,to present at ...ceuticals Transcept Pharmaceuticals, Inc. is a sp...
...Family Coverage Now Average $12,106, With Workers,...en Health Plans Remains Modest, WASHINGTON, Sept....nce rose an average of 6.1 percent in 2007,less th...ercent), according to the 2007 Employer Health Ben...
... diet rich in fish and fruity vegetables can reduc...study of 460 Spanish children, published in the Se... , The findings also reinforce the researchers e...that has assessed the impact of a childs diet on a...
Other Medicine News:Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 2Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 3Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 4Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 5Health News:U of M study: Health food supplement may curb addiction of pathological gamblers 2Health News:Additional Top Tier Institutions Implement Mediware's HCLL(TM) Transfusion Management Software 2Health News:Health Insurance Premiums Rise 6.1 Percent in 2007, Less Rapidly Than in Recent Years But Still Faster Than Wages and Inflation 2Health News:Health Insurance Premiums Rise 6.1 Percent in 2007, Less Rapidly Than in Recent Years But Still Faster Than Wages and Inflation 3Health News:Health Insurance Premiums Rise 6.1 Percent in 2007, Less Rapidly Than in Recent Years But Still Faster Than Wages and Inflation 4Health News:Health Insurance Premiums Rise 6.1 Percent in 2007, Less Rapidly Than in Recent Years But Still Faster Than Wages and Inflation 5Health News:Health Insurance Premiums Rise 6.1 Percent in 2007, Less Rapidly Than in Recent Years But Still Faster Than Wages and Inflation 6Health News:Health Insurance Premiums Rise 6.1 Percent in 2007, Less Rapidly Than in Recent Years But Still Faster Than Wages and Inflation 7Health News:'Fruity vegetables' and fish reduce asthma and allergies 2
Endotrol® Tracheal Tube with Controllable Tip
Intermediate Hi-Lo® Tracheal Tube
Hi-Lo® Tracheal Tube
...el 1 H-1200 Fast Flow Fluid Warmer, a new generati...of the existing Level 1 Fast Flow Fluid Warmer leg... incorporates the features of integrated air detec...inuing to deliver warm fluids as fast as 1,000 ml/...
Medicine Products: